Continuous Manufacturing Market By Product (Integrated system, Semi-continuous (Granulator, Coater, Blender), Control), Application (API, End Product (Solid Dosage)), End User (R&D Department (CRO), Pharmaceutical Companies, CMO) - Global Forecast to 2022
The global continuous manufacturing market is expected to reach USD 650.4 million by 2022 from USD 348.5 million in 2017, at a CAGR of 13.3%.
The market is segmented on the basis of product, application, end user, and geography. The product segment includes integrated systems, semi-continuous systems, and controls. The integrated systems segment is expected to account for the largest share of the continuous manufacturing market in 2017. The integrated systems enable end-to-end manufacturing to convert raw materials into final products. In addition, these systems save substantial cost and time by integrating various pharmaceutical processes in a single system.
By application, the end product manufacturing segment is estimated to account for the largest share of the market, in 2017. FDA approval for certain drugs manufactured by the continuous process is the primary factor driving the growth of this segment.
On the basis of end user, the full-scale manufacturing companies are expected to hold the highest share of the market, in 2017. The large share of this segment can primarily be attributed to the increasing adoption of continuous technologies by pharmaceutical manufacturing companies and CMOs to address the challenges related to product quality, drug supply, and operational costs.
Product launch was the dominant strategy adopted by key industry participants to increase their market share and cater to unmet needs. Major players include GEA Group AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Bosch Packaging Technology (Germany), Coperion GmbH (Germany), and Glatt GmbH (Germany). Other players include KORSCH AG (Germany), Munson Machinery Company, Inc. (U.S.), L.B. Bohle Maschinen + Verfahren Gmbh (Germany), Gebr?der L?dige Maschinenbau GmbH (Germany), Baker Perkins Ltd. (U.K.), Scott Equipment Company (U.S.), and Sturtevant, Inc. (U.S.).
Research Coverage:
This report studies the continuous manufacturing market based on product, application, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends, prospects, and contributions to the total market. The report forecasts revenue of the market segments with respect to four main regions.
Reasons to Buy the Report:
The report will enable both established firms and new entrants to gauge the pulse of the market and to help them make important strategic growth decisions.
The report provides insights on the following:
The market is segmented on the basis of product, application, end user, and geography. The product segment includes integrated systems, semi-continuous systems, and controls. The integrated systems segment is expected to account for the largest share of the continuous manufacturing market in 2017. The integrated systems enable end-to-end manufacturing to convert raw materials into final products. In addition, these systems save substantial cost and time by integrating various pharmaceutical processes in a single system.
By application, the end product manufacturing segment is estimated to account for the largest share of the market, in 2017. FDA approval for certain drugs manufactured by the continuous process is the primary factor driving the growth of this segment.
On the basis of end user, the full-scale manufacturing companies are expected to hold the highest share of the market, in 2017. The large share of this segment can primarily be attributed to the increasing adoption of continuous technologies by pharmaceutical manufacturing companies and CMOs to address the challenges related to product quality, drug supply, and operational costs.
Product launch was the dominant strategy adopted by key industry participants to increase their market share and cater to unmet needs. Major players include GEA Group AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Bosch Packaging Technology (Germany), Coperion GmbH (Germany), and Glatt GmbH (Germany). Other players include KORSCH AG (Germany), Munson Machinery Company, Inc. (U.S.), L.B. Bohle Maschinen + Verfahren Gmbh (Germany), Gebr?der L?dige Maschinenbau GmbH (Germany), Baker Perkins Ltd. (U.K.), Scott Equipment Company (U.S.), and Sturtevant, Inc. (U.S.).
Research Coverage:
This report studies the continuous manufacturing market based on product, application, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends, prospects, and contributions to the total market. The report forecasts revenue of the market segments with respect to four main regions.
Reasons to Buy the Report:
The report will enable both established firms and new entrants to gauge the pulse of the market and to help them make important strategic growth decisions.
The report provides insights on the following:
- Product Development/Innovation: Product portfolios of the top players in the continuous manufacturing market. Detailed insights on upcoming technologies, R&D activities, and product launches on the upcoming continuous manufacturing market
- Competitive Assessment: In-depth assessment of market shares, strategies, geographic and business segments, and product portfolios of the leading players in the continuous manufacturing market
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various continuous manufacturing systems across geographies
- Market Diversification: Exhaustive information about new products, recent developments, and investments in the continuous manufacturing market
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
2.1.1 KEY DATA FROM SECONDARY SOURCES
2.1.2 KEY DATA FROM PRIMARY SOURCES
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.3 ASSUMPTION
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 CONTINUOUS MANUFACTURING: MARKET OVERVIEW (2017 VS. 2022)
4.2 GEOGRAPHIC ANALYSIS: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY PRODUCT & BY REGION (2016)
4.3 PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY APPLICATION, 2017 VS. 2022
4.4 PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY END USER, 2017 VS. 2022
4.5 GEOGRAPHIC SNAPSHOT OF THE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET
4.6 BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY PRODUCT, 2017 VS. 2022
4.7 BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY END USER, 2017 VS. 2022
4.8 GEOGRAPHIC SNAPSHOT OF THE BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET
5 CONTINUOUS MANUFACTURING MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Cost-effective approach for pharmaceutical manufacturing
5.2.1.2 Better efficiency of manufacturing operations offered by continuous processes
5.2.1.3 Support from regulatory authorities for the implementation of continuous manufacturing
5.2.2 RESTRAINTS
5.2.2.1 Lack of technical and regulatory clarity
5.2.3 OPPORTUNITIES
5.2.3.1 Industry-academia collaborations
5.2.3.2 Expected growth in generic and biosimilar manufacturing
5.2.4 CHALLENGES
5.2.4.1 Significant infrastructural investments and global regulatory uncertainty
5.2.4.2 Concerns related to cleaning validation in continuous manufacturing
6 CONTINUOUS MANUFACTURING MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 INTEGRATED SYSTEMS
6.3 SEMI-CONTINUOUS SYSTEMS
6.3.1 CONTINUOUS GRANULATORS
6.3.2 CONTINUOUS BLENDERS
6.3.3 CONTINUOUS COMPRESSORS
6.3.4 CONTINUOUS COATERS
6.3.5 CONTINUOUS DRYERS
6.3.6 OTHER SEMI-CONTINUOUS SYSTEMS
6.4 CONTROLS
6.5 UPSTREAM PROCESSING EQUIPMENT
6.5.1 BIOREACTORS
6.5.2 CELL RETENTION SYSTEMS (CRS)
6.6 DOWNSTREAM PROCESSING EQUIPMENT
6.6.1 CHROMATOGRAPHY
6.6.2 FILTRATION SYSTEMS
7 PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY APPLICATION
7.1 INTRODUCTION
7.2 END PRODUCT MANUFACTURING
7.2.1 SOLID DOSE PHARMACEUTICAL MANUFACTURING
7.2.2 LIQUID DOSE PHARMACEUTICAL MANUFACTURING
7.3 API MANUFACTURING
8 PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY END USER
8.1 INTRODUCTION
8.2 FULL-SCALE MANUFACTURING COMPANIES
8.2.1 PHARMACEUTICAL COMPANIES
8.2.2 CONTRACT MANUFACTURING ORGANIZATIONS
8.3 R&D DEPARTMENTS
8.3.1 CONTRACT RESEARCH ORGANIZATIONS
8.3.2 RESEARCH INSTITUTES
8.4 MANUFACTURING COMPANIES
8.5 RESEARCH AND DEVELOPMENT DEPARTMENTS
9 CONTINUOUS MANUFACTURING MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 U.S.
9.2.2 CANADA
9.3 EUROPE
9.3.1 GERMANY
9.3.2 U.K.
9.3.3 REST OF EUROPE
9.4 ASIA-PACIFIC
9.4.1 SINGAPORE
9.4.2 CHINA
9.4.3 JAPAN
9.4.4 REST OF ASIA-PACIFIC
9.5 REST OF THE WORLD (ROW)
10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 MARKET RANKING (INTEGRATED SYSTEMS)
10.3 MARKET RANKING (BIOREACTORS)
10.4 MARKET RANKING (CELL RETENTION SYSTEMS)
10.5 COMPETITIVE LEADERSHIP MAPPING
10.5.1 VANGUARDS
10.5.2 INNOVATORS
10.5.3 DYNAMIC
10.5.4 EMERGING
10.6 COMPETITIVE BENCHMARKING
10.6.1 PRODUCT OFFERINGS
10.6.2 BUSINESS STRATEGY
11 COMPANY PROFILES
(Business overview, Products offered, Company Scorecard, Recent Developments)*
11.1 THERMO FISHER SCIENTIFIC INC.
11.2 GEA GROUP AG
11.3 HOSOKAWA MICRON CORPORATION
11.4 COPERION GMBH
11.5 GLATT GMBH
11.6 KORSCH AG
11.7 MUNSON MACHINERY COMPANY, INC.
11.8 L.B. BOHLE MASCHINEN + VERFAHREN GMBH
11.9 BOSCH PACKAGING TECHNOLOGY
11.10 GEBRÜDER LÖDIGE MASCHINENBAU GMBH
11.11 BAKER PERKINS LTD.
11.12 SCOTT EQUIPMENT COMPANY
11.13 STURTEVANT, INC.
11.14 SARTORIUS STEDIM BIOTECH SA (SSB)
11.15 GE HEALTHCARE
11.16 MERCK MILLIPORE
11.17 REPLIGEN
11.18 DANAHER CORPORATION
*Details on Business overview, Products offered, Company Scorecard, Recent Developments might not be captured in case of unlisted companies.
12 APPENDIX
12.1 INSIGHTS OF INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
12.5 AVAILABLE CUSTOMIZATIONS
12.6 RELATED REPORTS
12.7 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
2.1.1 KEY DATA FROM SECONDARY SOURCES
2.1.2 KEY DATA FROM PRIMARY SOURCES
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.3 ASSUMPTION
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 CONTINUOUS MANUFACTURING: MARKET OVERVIEW (2017 VS. 2022)
4.2 GEOGRAPHIC ANALYSIS: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY PRODUCT & BY REGION (2016)
4.3 PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY APPLICATION, 2017 VS. 2022
4.4 PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY END USER, 2017 VS. 2022
4.5 GEOGRAPHIC SNAPSHOT OF THE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET
4.6 BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY PRODUCT, 2017 VS. 2022
4.7 BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY END USER, 2017 VS. 2022
4.8 GEOGRAPHIC SNAPSHOT OF THE BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET
5 CONTINUOUS MANUFACTURING MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Cost-effective approach for pharmaceutical manufacturing
5.2.1.2 Better efficiency of manufacturing operations offered by continuous processes
5.2.1.3 Support from regulatory authorities for the implementation of continuous manufacturing
5.2.2 RESTRAINTS
5.2.2.1 Lack of technical and regulatory clarity
5.2.3 OPPORTUNITIES
5.2.3.1 Industry-academia collaborations
5.2.3.2 Expected growth in generic and biosimilar manufacturing
5.2.4 CHALLENGES
5.2.4.1 Significant infrastructural investments and global regulatory uncertainty
5.2.4.2 Concerns related to cleaning validation in continuous manufacturing
6 CONTINUOUS MANUFACTURING MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 INTEGRATED SYSTEMS
6.3 SEMI-CONTINUOUS SYSTEMS
6.3.1 CONTINUOUS GRANULATORS
6.3.2 CONTINUOUS BLENDERS
6.3.3 CONTINUOUS COMPRESSORS
6.3.4 CONTINUOUS COATERS
6.3.5 CONTINUOUS DRYERS
6.3.6 OTHER SEMI-CONTINUOUS SYSTEMS
6.4 CONTROLS
6.5 UPSTREAM PROCESSING EQUIPMENT
6.5.1 BIOREACTORS
6.5.2 CELL RETENTION SYSTEMS (CRS)
6.6 DOWNSTREAM PROCESSING EQUIPMENT
6.6.1 CHROMATOGRAPHY
6.6.2 FILTRATION SYSTEMS
7 PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY APPLICATION
7.1 INTRODUCTION
7.2 END PRODUCT MANUFACTURING
7.2.1 SOLID DOSE PHARMACEUTICAL MANUFACTURING
7.2.2 LIQUID DOSE PHARMACEUTICAL MANUFACTURING
7.3 API MANUFACTURING
8 PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY END USER
8.1 INTRODUCTION
8.2 FULL-SCALE MANUFACTURING COMPANIES
8.2.1 PHARMACEUTICAL COMPANIES
8.2.2 CONTRACT MANUFACTURING ORGANIZATIONS
8.3 R&D DEPARTMENTS
8.3.1 CONTRACT RESEARCH ORGANIZATIONS
8.3.2 RESEARCH INSTITUTES
8.4 MANUFACTURING COMPANIES
8.5 RESEARCH AND DEVELOPMENT DEPARTMENTS
9 CONTINUOUS MANUFACTURING MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 U.S.
9.2.2 CANADA
9.3 EUROPE
9.3.1 GERMANY
9.3.2 U.K.
9.3.3 REST OF EUROPE
9.4 ASIA-PACIFIC
9.4.1 SINGAPORE
9.4.2 CHINA
9.4.3 JAPAN
9.4.4 REST OF ASIA-PACIFIC
9.5 REST OF THE WORLD (ROW)
10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 MARKET RANKING (INTEGRATED SYSTEMS)
10.3 MARKET RANKING (BIOREACTORS)
10.4 MARKET RANKING (CELL RETENTION SYSTEMS)
10.5 COMPETITIVE LEADERSHIP MAPPING
10.5.1 VANGUARDS
10.5.2 INNOVATORS
10.5.3 DYNAMIC
10.5.4 EMERGING
10.6 COMPETITIVE BENCHMARKING
10.6.1 PRODUCT OFFERINGS
10.6.2 BUSINESS STRATEGY
11 COMPANY PROFILES
(Business overview, Products offered, Company Scorecard, Recent Developments)*
11.1 THERMO FISHER SCIENTIFIC INC.
11.2 GEA GROUP AG
11.3 HOSOKAWA MICRON CORPORATION
11.4 COPERION GMBH
11.5 GLATT GMBH
11.6 KORSCH AG
11.7 MUNSON MACHINERY COMPANY, INC.
11.8 L.B. BOHLE MASCHINEN + VERFAHREN GMBH
11.9 BOSCH PACKAGING TECHNOLOGY
11.10 GEBRÜDER LÖDIGE MASCHINENBAU GMBH
11.11 BAKER PERKINS LTD.
11.12 SCOTT EQUIPMENT COMPANY
11.13 STURTEVANT, INC.
11.14 SARTORIUS STEDIM BIOTECH SA (SSB)
11.15 GE HEALTHCARE
11.16 MERCK MILLIPORE
11.17 REPLIGEN
11.18 DANAHER CORPORATION
*Details on Business overview, Products offered, Company Scorecard, Recent Developments might not be captured in case of unlisted companies.
12 APPENDIX
12.1 INSIGHTS OF INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
12.5 AVAILABLE CUSTOMIZATIONS
12.6 RELATED REPORTS
12.7 AUTHOR DETAILS
LIST OF TABLES
Table 1 CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2015–2022 (USD MILLION)
Table 2 PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2015–2022 (USD MILLION)
Table 3 CONTINUOUS MANUFACTURING MARKET SIZE FOR INTEGRATED SYSTEMS, BY REGION, 2015–2022 (USD MILLION)
Table 4 NORTH AMERICA: CONTINUOUS MANUFACTURING MARKET SIZE FOR INTEGRATED SYSTEMS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 5 EUROPE: CONTINUOUS MANUFACTURING MARKET SIZE FOR INTEGRATED SYSTEMS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 6 ASIA-PACIFIC: CONTINUOUS MANUFACTURING MARKET SIZE FOR INTEGRATED SYSTEMS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 7 CONTINUOUS MANUFACTURING MARKET SIZE FOR SEMI-CONTINUOUS SYSTEMS, BY TYPE, 2015–2022 (USD MILLION)
Table 8 CONTINUOUS MANUFACTURING MARKET SIZE FOR SEMI-CONTINUOUS SYSTEMS, BY REGION, 2015–2022 (USD MILLION)
Table 9 NORTH AMERICA: CONTINUOUS MANUFACTURING MARKET SIZE FOR SEMI-CONTINUOUS SYSTEMS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 10 EUROPE: CONTINUOUS MANUFACTURING MARKET SIZE FOR SEMI-CONTINUOUS SYSTEMS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 11 ASIA-PACIFIC: CONTINUOUS MANUFACTURING MARKET SIZE FOR SEMI-CONTINUOUS SYSTEMS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 12 CONTINUOUS GRANULATORS MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
Table 13 NORTH AMERICA: CONTINUOUS GRANULATORS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 14 EUROPE: CONTINUOUS GRANULATORS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 15 ASIA-PACIFIC: CONTINUOUS GRANULATORS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 16 CONTINUOUS BLENDERS MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
Table 17 NORTH AMERICA: CONTINUOUS BLENDERS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 18 EUROPE: CONTINUOUS BLENDERS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 19 ASIA-PACIFIC: CONTINUOUS BLENDERS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 20 CONTINUOUS COMPRESSORS MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
Table 21 NORTH AMERICA: CONTINUOUS COMPRESSORS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 22 EUROPE: CONTINUOUS COMPRESSORS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 23 ASIA-PACIFIC: CONTINUOUS COMPRESSORS MARKET SIZE, BY COUNTRY, 2015–2022 (USD THOUSAND)
Table 24 CONTINUOUS COATERS MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
Table 25 NORTH AMERICA: CONTINUOUS COATERS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 26 EUROPE: CONTINUOUS COATERS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 27 ASIA-PACIFIC: CONTINUOUS COATERS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 28 CONTINUOUS DRYERS MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
Table 29 NORTH AMERICA: CONTINUOUS DRYERS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 30 EUROPE: CONTINUOUS DRYERS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 31 ASIA-PACIFIC: CONTINUOUS DRYERS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 32 OTHER SEMI-CONTINUOUS SYSTEMS MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
Table 33 NORTH AMERICA: OTHER SEMI-CONTINUOUS SYSTEMS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 34 EUROPE: OTHER SEMI-CONTINUOUS SYSTEMS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 35 ASIA-PACIFIC: OTHER SEMI-CONTINUOUS SYSTEMS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 36 CONTINUOUS MANUFACTURING MARKET SIZE FOR CONTROLS, BY REGION, 2015–2022 (USD MILLION)
Table 37 NORTH AMERICA: CONTROLS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 38 EUROPE: CONTROLS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 39 ASIA-PACIFIC: CONTROLS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 40 BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2015–2022 (USD MILLION)
Table 41 BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, FOR UPSTREAM PROCESSING PRODUCTS, 2015–2022 (USD MILLION)
Table 42 BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, FOR UPSTREAM PROCESSING EQUIPMENT, BY REGION, 2015–2022 (USD MILLION)
Table 43 NORTH AMERICA: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, FOR UPSTREAM PROCESSING EQUIPMENT, BY COUNTRY, 2015–2022 (USD MILLION)
Table 44 ASIA-PACIFIC: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, FOR UPSTREAM PROCESSING EQUIPMENT, BY COUNTRY, 2015–2022 (USD MILLION)
Table 45 EUROPE: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, FOR UPSTREAM PROCESSING EQUIPMENT, BY COUNTRY, 2015–2022 (USD MILLION)
Table 46 NORTH AMERICA: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, FOR BIOREACTORS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 47 EUROPE: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, FOR BIOREACTORS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 48 ASIA-PACIFIC: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, FOR BIOREACTORS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 49 NORTH AMERICA: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, FOR CRS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 50 EUROPE: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, FOR CRS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 51 ASIA-PACIFIC: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, FOR CRS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 52 BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR DOWNSTREAM PROCESSING EQUIPMENT, BY PRODUCT, 2015–2022 (USD MILLION)
Table 53 BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR DOWNSTREAM PROCESSING EQUIPMENT, BY REGION, 2015–2022 (USD MILLION)
Table 54 NORTH AMERICA: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR DOWNSTREAM PROCESSING EQUIPMENT, BY COUNTRY, 2015–2022 (USD MILLION)
Table 55 EUROPE: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, FOR DOWNSTREAM PROCESSING EQUIPMENT, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
Table 56 ASIA-PACIFIC: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, FOR DOWNSTREAM PROCESSING EQUIPMENT, BY COUNTRY, 2015–2022 (USD MILLION)
Table 57 NORTH AMERICA: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, FOR CHROMATOGRAPHY SYSTEMS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 58 EUROPE: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, FOR CHROMATOGRAPHY SYSTEMS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 59 ASIA-PACIFIC: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, FOR CHROMATOGRAPHY SYSTEMS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 60 NORTH AMERICA: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, FOR FLITRATION SYSTEMS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 61 EUROPE: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, FOR FLITRATION SYSTEMS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 62 ASIA-PACIFIC: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, FOR FILTRATION SYSTEMS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 63 PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 64 PHARMACEUTICAL CONTINUOUS END PRODUCT MANUFACTURING MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
Table 65 NORTH AMERICA: PHARMACEUTICAL CONTINUOUS END PRODUCT MANUFACTURING MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 66 EUROPE: PHARMACEUTICAL CONTINUOUS END PRODUCT MANUFACTURING MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 67 ASIA-PACIFIC: PHARMACEUTICAL CONTINUOUS END PRODUCT MANUFACTURING MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 68 PHARMACEUTICAL CONTINUOUS END PRODUCT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2015–2022 (USD MILLION)
Table 69 PHARMACEUTICAL CONTINUOUS SOLID DOSE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
Table 70 NORTH AMERICA: PHARMACEUTICAL CONTINUOUS SOLID DOSE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 71 EUROPE: PHARMACEUTICAL CONTINUOUS SOLID DOSE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 72 ASIA-PACIFIC: PHARMACEUTICAL CONTINUOUS SOLID DOSE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 73 PHARMACEUTICAL CONTINUOUS LIQUID DOSE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
Table 74 NORTH AMERICA: PHARMACEUTICAL CONTINUOUS LIQUID DOSE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 75 EUROPE: CONTINUOUS LIQUID DOSE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 76 ASIA-PACIFIC: PHARMACEUTICAL CONTINUOUS LIQUID DOSE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 77 PHARMACEUTICAL CONTINUOUS API MANUFACTURING MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
Table 78 NORTH AMERICA: PHARMACEUTICAL CONTINUOUS API MANUFACTURING MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 79 EUROPE: PHARMACEUTICAL CONTINUOUS API MANUFACTURING MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 80 ASIA-PACIFIC: PHARMACEUTICAL CONTINUOUS API MANUFACTURING MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 81 PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2015–2022 (USD MILLION)
Table 82 PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR FULL-SCALE MANUFACTURING COMPANIES, BY TYPE, 2015–2022 (USD MILLION)
Table 83 PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR FULL-SCALE MANUFACTURING COMPANIES, BY REGION, 2015–2022 (USD MILLION)
Table 84 NORTH AMERICA: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR FULL-SCALE MANUFACTURING COMPANIES, BY COUNTRY, 2015–2022 (USD MILLION)
Table 85 EUROPE: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR FULL-SCALE MANUFACTURING COMPANIES, BY COUNTRY, 2015–2022 (USD MILLION)
Table 86 ASIA-PACIFIC: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR FULL-SCALE MANUFACTURING COMPANIES, BY COUNTRY, 2015–2022 (USD MILLION)
Table 87 PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR PHARMACEUTICAL COMPANIES, BY REGION, 2015–2022 (USD MILLION)
Table 88 NORTH AMERICA: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2015–2022 (USD MILLION)
Table 89 EUROPE: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2015–2022 (USD MILLION)
Table 90 ASIA-PACIFIC: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2015–2022 (USD MILLION)
Table 91 PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2015–2022 (USD MILLION)
Table 92 ASIA-PACIFIC: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR CONTRACT MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 93 NORTH AMERICA: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR CONTRACT MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 94 EUROPE: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR CONTRACT MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 95 PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR R&D DEPARTMENTS, BY TYPE, 2015–2022 (USD MILLION)
Table 96 PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR R&D DEPARTMENTS, BY REGION, 2015–2022 (USD MILLION)
Table 97 NORTH AMERICA: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR R&D DEPARTMENTS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 98 EUROPE: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR R&D DEPARTMENTS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 99 APAC: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR R&D DEPARTMENTS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 100 PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2015–2022 (USD MILLION)
Table 101 NORTH AMERICA: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 102 EUROPE: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 103 ASIA-PACIFIC: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 104 PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR RESEARCH INSTITUTES, BY REGION, 2015–2022 (USD MILLION)
Table 105 NORTH AMERICA: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR RESEARCH INSTITUTES, BY COUNTRY, 2015–2022 (USD MILLION)
Table 106 EUROPE: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR RESEARCH INSTITUTES, BY COUNTRY, 2015–2022 (USD MILLION)
Table 107 ASIA-PACIFIC: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR RESEARCH INSTITUTES, BY COUNTRY, 2015–2022 (USD MILLION)
Table 108 BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2015–2022 (USD MILLION)
Table 109 BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR MANUFACTURING COMPANIES, BY REGION, 2015–2022 (USD MILLION)
Table 110 NORTH AMERICA: CONTINUOUS MANUFACTURING MARKET SIZE FOR FULL-SCALE MANUFACTURING COMPANIES, BY COUNTRY, 2015–2022 (USD MILLION)
Table 111 ASIA-PACIFIC: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR FULL-SCALE MANUFACTURING COMPANIES, BY COUNTRY, 2015–2022 (USD MILLION)
Table 112 EUROPE: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR FULL-SCALE MANUFACTURING COMPANIES, BY COUNTRY, 2015–2022 (USD MILLION)
Table 113 BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR R&D DEPARTMENTS, BY REGION, 2015–2022 (USD MILLION)
Table 114 NORTH AMERICA: CONTINUOUS MANUFACTURING MARKET SIZE FOR R&D DEPARTMENTS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 115 EUROPE: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR R&D DEPARTMENTS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 116 APAC: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR R&D DEPARTMENTS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 117 GLOBAL CONTINUOUS MANUFACTURING MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
Table 118 GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
Table 119 GLOBAL BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
Table 120 NORTH AMERICA: CONTINUOUS MANUFACTURING MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 121 NORTH AMERICA: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 122 NORTH AMERICA: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2015–2022 (USD MILLION)
Table 123 NORTH AMERICA: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 124 NORTH AMERICA: PHARMACEUTICAL END PRODUCT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2015–2022 (USD MILLION)
Table 125 NORTH AMERICA: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2015–2022 (USD MILLION)
Table 126 NORTH AMERICA: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR FULL-SCALE MANUFACTURING COMPANIES, BY TYPE, 2015–2022 (USD MILLION)
Table 127 NORTH AMERICA: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR R&D DEPARTMENTS, BY TYPE, 2015–2022 (USD MILLION)
Table 128 NORTH AMERICA: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 129 NORTH AMERICA: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY EQUIPMENT, 2015–2022 (USD MILLION)
Table 130 NORTH AMERICA: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY UPSTREAM EQUIPMENT, 2015–2022 (USD MILLION)
Table 131 NORTH AMERICA: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DOWNSTREAM EQUIPMENT, 2015–2022 (USD MILLION)
Table 132 NORTH AMERICA: CONTINUOUS MANUFACTURING MARKET SIZE, BY END-USER, 2015–2022 (USD MILLION)
Table 133 U.S.: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2015–2022 (USD MILLION)
Table 134 U.S.: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 135 U.S.: PHARMACEUTICAL END PRODUCT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2015–2022 (USD MILLION)
Table 136 U.S.: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2015–2022 (USD MILLION)
Table 137 U.S.: CONTINUOUS MANUFACTURING MARKET SIZE FOR FULL-SCALE MANUFACTURING COMPANIES, BY TYPE, 2015–2022 (USD MILLION)
Table 138 U.S.: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR R&D DEPARTMENTS, BY TYPE, 2015–2022 (USD MILLION)
Table 139 U.S.: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY EQUIPMENT, 2015–2022 (USD MILLION)
Table 140 U.S.: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY UPSTREAM EQUIPMENT, 2015–2022 (USD MILLION)
Table 141 U.S.: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DOWNSTREAM EQUIPMENT, 2015–2022 (USD MILLION)
Table 142 U.S.: CONTINUOUS MANUFACTURING MARKET SIZE, BY END-USER, 2015–2022 (USD MILLION)
Table 143 CANADA: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2015–2022 (USD MILLION)
Table 144 CANADA: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 145 CANADA: PHARMACEUTICAL END PRODUCT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2015–2022 (USD MILLION)
Table 146 CANADA: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2015–2022 (USD MILLION)
Table 147 CANADA: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR FULL-SCALE MANUFACTURING COMPANIES, BY TYPE, 2015–2022 (USD MILLION)
Table 148 CANADA: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR R&D DEPARTMENTS, BY TYPE, 2015–2022 (USD MILLION)
Table 149 CANADA: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY EQUIPMENT, 2015–2022 (USD MILLION)
Table 150 CANADA: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY UPSTREAM EQUIPMENT, 2015–2022 (USD MILLION)
Table 151 CANADA: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DOWNSTREAM EQUIPMENT, 2015–2022 (USD MILLION)
Table 152 CANADA: CONTINUOUS MANUFACTURING MARKET SIZE, BY END-USER, 2015–2022 (USD MILLION)
Table 153 EUROPE: CONTINUOUS MANUFACTURING MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 154 EUROPE: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2015–2022 (USD MILLION)
Table 155 EUROPE: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 156 EUROPE: PHARMACEUTICAL END PRODUCT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2015–2022 (USD MILLION)
Table 157 EUROPE: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2015–2022 (USD MILLION)
Table 158 EUROPE: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR FULL-SCALE MANUFACTURING COMPANIES, BY TYPE, 2015–2022 (USD MILLION)
Table 159 EUROPE: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR R&D DEPARTMENTS, BY TYPE, 2015–2022 (USD MILLION)
Table 160 EUROPE: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 161 EUROPE: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY EQUIPMENT, 2015–2022 (USD MILLION)
Table 162 EUROPE: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY UPSTREAM EQUIPMENT, 2015–2022 (USD MILLION)
Table 163 EUROPE: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DOWNSTREAM EQUIPMENT, 2015–2022 (USD MILLION)
Table 164 EUROPE: CONTINUOUS MANUFACTURING MARKET SIZE, BY END-USER, 2015–2022 (USD MILLION)
Table 165 GERMANY: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2015–2022 (USD MILLION)
Table 166 GERMANY: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 167 GERMANY: END PRODUCT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2015–2022 (USD MILLION)
Table 168 GERMANY: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2015–2022 (USD MILLION)
Table 169 GERMANY: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR FULL-SCALE MANUFACTURING COMPANIES, BY TYPE, 2015–2022 (USD MILLION)
Table 170 GERMANY: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR R&D DEPARTMENTS, BY TYPE, 2015–2022 (USD MILLION)
Table 171 GERMANY: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY EQUIPMENT, 2015–2022 (USD MILLION)
Table 172 GERMANY: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY UPSTREAM EQUIPMENT, 2015–2022 (USD MILLION)
Table 173 GERMANY: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DOWNSTREAM EQUIPMENT, 2015–2022 (USD MILLION)
Table 174 GERMANY: CONTINUOUS MANUFACTURING MARKET SIZE, BY END-USER, 2015–2022 (USD MILLION)
Table 175 U.K.: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2015–2022 (USD MILLION)
Table 176 U.K.: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 177 U.K.: PHARMACEUTICAL END PRODUCT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2015–2022 (USD MILLION)
Table 178 U.K.: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2015–2022 (USD MILLION)
Table 179 U.K.: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR FULL-SCALE MANUFACTURING COMPANIES, BY TYPE, 2015–2022 (USD MILLION)
Table 180 U.K.: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR R&D DEPARTMENTS, BY TYPE, 2015–2022 (USD MILLION)
Table 181 U.K.: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY EQUIPMENT, 2015–2022 (USD MILLION)
Table 182 U.K.: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY UPSTREAM EQUIPMENT, 2015–2022 (USD MILLION)
Table 183 U.K.: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DOWNSTREAM EQUIPMENT, 2015–2022 (USD MILLION)
Table 184 U.K.: CONTINUOUS MANUFACTURING MARKET SIZE, BY END-USER, 2015–2022 (USD MILLION)
Table 185 REST OF EUROPE: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2015–2022 (USD MILLION)
Table 186 REST OF EUROPE: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 187 REST OF EUROPE: PHARMACEUTICAL END PRODUCT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2015–2022 (USD MILLION)
Table 188 REST OF EUROPE: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2015–2022 (USD MILLION)
Table 189 REST OF EUROPE: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR FULL-SCALE MANUFACTURING COMPANIES, BY TYPE, 2015–2022 (USD MILLION)
Table 190 REST OF EUROPE: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR R&D DEPARTMENTS, BY TYPE, 2015–2022 (USD MILLION)
Table 191 ROE: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY EQUIPMENT, 2015–2022 (USD MILLION)
Table 192 ROE: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY UPSTREAM EQUIPMENT, 2015–2022 (USD MILLION)
Table 193 ROE: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DOWNSTREAM EQUIPMENT, 2015–2022 (USD MILLION)
Table 194 ROE: CONTINUOUS MANUFACTURING MARKET SIZE, BY END-USER, 2015–2022 (USD MILLION)
Table 195 APAC: CONTINUOUS MANUFACTURING MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 196 APAC: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 197 APAC: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2015–2022 (USD MILLION)
Table 198 APAC: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 199 APAC: PHARMACEUTICAL END PRODUCT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2015–2022 (USD MILLION)
Table 200 APAC: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2015–2022 (USD MILLION)
Table 201 APAC: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR FULL-SCALE MANUFACTURING COMPANIES, BY TYPE, 2015–2022 (USD MILLION)
Table 202 APAC: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR R&D DEPARTMENTS, BY TYPE, 2015–2022 (USD MILLION)
Table 203 APAC: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 204 APAC: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY EQUIPMENT, 2015–2022 (USD MILLION)
Table 205 APAC: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY UPSTREAM EQUIPMENT, 2015–2022 (USD MILLION)
Table 206 APAC: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DOWNSTREAM EQUIPMENT, 2015–2022 (USD MILLION)
Table 207 APAC: CONTINUOUS MANUFACTURING MARKET SIZE, BY END-USER, 2015–2022 (USD MILLION)
Table 208 SINGAPORE: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2015–2022 (USD MILLION)
Table 209 SINGAPORE: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 210 SINGAPORE: PHARMACEUTICAL END PRODUCT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2015–2022 (USD MILLION)
Table 211 SINGAPORE: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2015–2022 (USD MILLION)
Table 212 SINGAPORE: CONTINUOUS MANUFACTURING MARKET SIZE FOR FULL-SCALE MANUFACTURING COMPANIES, BY TYPE, 2015–2022 (USD MILLION)
Table 213 SINGAPORE: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR R&D DEPARTMENTS, BY TYPE, 2015–2022 (USD MILLION)
Table 214 SINGAPORE: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY EQUIPMENT, 2015–2022 (USD MILLION)
Table 215 SINGAPORE: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY UPSTREAM EQUIPMENT, 2015–2022 (USD MILLION)
Table 216 SINGAPORE: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DOWNSTREAM EQUIPMENT, 2015–2022 (USD MILLION)
Table 217 SINGAPORE: CONTINUOUS MANUFACTURING MARKET SIZE, BY END-USER, 2015–2022 (USD MILLION)
Table 218 CHINA: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2015–2022 (USD MILLION)
Table 219 CHINA: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 220 CHINA: PHARMACEUTICAL END PRODUCT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2015–2022 (USD MILLION)
Table 221 CHINA: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2015–2022 (USD MILLION)
Table 222 CHINA: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR FULL-SCALE MANUFACTURING COMPANIES, BY TYPE, 2015–2022 (USD MILLION)
Table 223 CHINA: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR R&D DEPARTMENTS, BY TYPE, 2015–2022 (USD MILLION)
Table 224 CHINA: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY EQUIPMENT, 2015–2022 (USD MILLION)
Table 225 CHINA: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY UPSTREAM EQUIPMENT, 2015–2022 (USD MILLION)
Table 226 CHINA: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DOWNSTREAM EQUIPMENT, 2015–2022 (USD MILLION)
Table 227 CHINA: CONTINUOUS MANUFACTURING MARKET SIZE, BY END-USER, 2015–2022 (USD MILLION)
Table 228 JAPAN: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2015–2022 (USD MILLION)
Table 229 JAPAN: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 230 JAPAN: PHARMACEUTICAL END PRODUCT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2015–2022 (USD MILLION)
Table 231 JAPAN: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2015–2022 (USD MILLION)
Table 232 JAPAN: CONTINUOUS MANUFACTURING MARKET SIZE FOR FULL-SCALE MANUFACTURING COMPANIES, BY TYPE, 2015–2022 (USD MILLION)
Table 233 JAPAN: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR R&D DEPARTMENTS, BY TYPE, 2015–2022 (USD MILLION)
Table 234 JAPAN: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY EQUIPMENT, 2015–2022 (USD MILLION)
Table 235 JAPAN: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY UPSTREAM EQUIPMENT, 2015–2022 (USD MILLION)
Table 236 JAPAN: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DOWNSTREAM EQUIPMENT, 2015–2022 (USD MILLION)
Table 237 JAPAN: CONTINUOUS MANUFACTURING MARKET SIZE, BY END-USER, 2015–2022 (USD MILLION)
Table 238 ROAPAC: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2015–2022 (USD MILLION)
Table 239 ROAPAC: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 240 ROAPAC: PHARMACEUTICAL END PRODUCT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2015–2022 (USD MILLION)
Table 241 ROAPAC: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2015–2022 (USD MILLION)
Table 242 ROAPAC: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR FULL-SCALE MANUFACTURING COMPANIES, BY TYPE, 2015–2022 (USD MILLION)
Table 243 ROAPAC: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR R&D DEPARTMENTS, BY TYPE, 2015–2022 (USD MILLION)
Table 244 ROAPAC: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY EQUIPMENT, 2015–2022 (USD MILLION)
Table 245 ROAPAC: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY UPSTREAM EQUIPMENT, 2015–2022 (USD MILLION)
Table 246 ROAPAC: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DOWNSTREAM EQUIPMENT, 2015–2022 (USD MILLION)
Table 247 ROAPAC: CONTINUOUS MANUFACTURING MARKET SIZE, BY END-USER, 2015–2022 (USD MILLION)
Table 248 ROW: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2015–2022 (USD THOUSAND)
Table 249 ROW: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 250 ROW: PHARMACEUTICAL END PRODUCT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2015–2022 (USD MILLION)
Table 251 ROW: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2015–2022 (USD MILLION)
Table 252 ROW: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR FULL-SCALE MANUFACTURING COMPANIES, BY TYPE, 2015–2022 (USD MILLION)
Table 253 ROW: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR R&D DEPARTMENTS, BY TYPE, 2015–2022 (USD MILLION)
Table 254 ROW: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY EQUIPMENT, 2015–2022 (USD MILLION)
Table 255 ROW: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY UPSTREAM EQUIPMENT, 2015–2022 (USD MILLION)
Table 256 ROW: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DOWNSTREAM EQUIPMENT, 2015–2022 (USD MILLION)
Table 257 ROW: CONTINUOUS MANUFACTURING MARKET SIZE, BY END-USER, 2015–2022 (USD MILLION)
Table 1 CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2015–2022 (USD MILLION)
Table 2 PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2015–2022 (USD MILLION)
Table 3 CONTINUOUS MANUFACTURING MARKET SIZE FOR INTEGRATED SYSTEMS, BY REGION, 2015–2022 (USD MILLION)
Table 4 NORTH AMERICA: CONTINUOUS MANUFACTURING MARKET SIZE FOR INTEGRATED SYSTEMS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 5 EUROPE: CONTINUOUS MANUFACTURING MARKET SIZE FOR INTEGRATED SYSTEMS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 6 ASIA-PACIFIC: CONTINUOUS MANUFACTURING MARKET SIZE FOR INTEGRATED SYSTEMS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 7 CONTINUOUS MANUFACTURING MARKET SIZE FOR SEMI-CONTINUOUS SYSTEMS, BY TYPE, 2015–2022 (USD MILLION)
Table 8 CONTINUOUS MANUFACTURING MARKET SIZE FOR SEMI-CONTINUOUS SYSTEMS, BY REGION, 2015–2022 (USD MILLION)
Table 9 NORTH AMERICA: CONTINUOUS MANUFACTURING MARKET SIZE FOR SEMI-CONTINUOUS SYSTEMS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 10 EUROPE: CONTINUOUS MANUFACTURING MARKET SIZE FOR SEMI-CONTINUOUS SYSTEMS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 11 ASIA-PACIFIC: CONTINUOUS MANUFACTURING MARKET SIZE FOR SEMI-CONTINUOUS SYSTEMS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 12 CONTINUOUS GRANULATORS MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
Table 13 NORTH AMERICA: CONTINUOUS GRANULATORS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 14 EUROPE: CONTINUOUS GRANULATORS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 15 ASIA-PACIFIC: CONTINUOUS GRANULATORS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 16 CONTINUOUS BLENDERS MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
Table 17 NORTH AMERICA: CONTINUOUS BLENDERS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 18 EUROPE: CONTINUOUS BLENDERS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 19 ASIA-PACIFIC: CONTINUOUS BLENDERS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 20 CONTINUOUS COMPRESSORS MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
Table 21 NORTH AMERICA: CONTINUOUS COMPRESSORS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 22 EUROPE: CONTINUOUS COMPRESSORS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 23 ASIA-PACIFIC: CONTINUOUS COMPRESSORS MARKET SIZE, BY COUNTRY, 2015–2022 (USD THOUSAND)
Table 24 CONTINUOUS COATERS MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
Table 25 NORTH AMERICA: CONTINUOUS COATERS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 26 EUROPE: CONTINUOUS COATERS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 27 ASIA-PACIFIC: CONTINUOUS COATERS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 28 CONTINUOUS DRYERS MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
Table 29 NORTH AMERICA: CONTINUOUS DRYERS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 30 EUROPE: CONTINUOUS DRYERS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 31 ASIA-PACIFIC: CONTINUOUS DRYERS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 32 OTHER SEMI-CONTINUOUS SYSTEMS MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
Table 33 NORTH AMERICA: OTHER SEMI-CONTINUOUS SYSTEMS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 34 EUROPE: OTHER SEMI-CONTINUOUS SYSTEMS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 35 ASIA-PACIFIC: OTHER SEMI-CONTINUOUS SYSTEMS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 36 CONTINUOUS MANUFACTURING MARKET SIZE FOR CONTROLS, BY REGION, 2015–2022 (USD MILLION)
Table 37 NORTH AMERICA: CONTROLS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 38 EUROPE: CONTROLS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 39 ASIA-PACIFIC: CONTROLS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 40 BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2015–2022 (USD MILLION)
Table 41 BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, FOR UPSTREAM PROCESSING PRODUCTS, 2015–2022 (USD MILLION)
Table 42 BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, FOR UPSTREAM PROCESSING EQUIPMENT, BY REGION, 2015–2022 (USD MILLION)
Table 43 NORTH AMERICA: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, FOR UPSTREAM PROCESSING EQUIPMENT, BY COUNTRY, 2015–2022 (USD MILLION)
Table 44 ASIA-PACIFIC: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, FOR UPSTREAM PROCESSING EQUIPMENT, BY COUNTRY, 2015–2022 (USD MILLION)
Table 45 EUROPE: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, FOR UPSTREAM PROCESSING EQUIPMENT, BY COUNTRY, 2015–2022 (USD MILLION)
Table 46 NORTH AMERICA: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, FOR BIOREACTORS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 47 EUROPE: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, FOR BIOREACTORS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 48 ASIA-PACIFIC: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, FOR BIOREACTORS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 49 NORTH AMERICA: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, FOR CRS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 50 EUROPE: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, FOR CRS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 51 ASIA-PACIFIC: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, FOR CRS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 52 BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR DOWNSTREAM PROCESSING EQUIPMENT, BY PRODUCT, 2015–2022 (USD MILLION)
Table 53 BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR DOWNSTREAM PROCESSING EQUIPMENT, BY REGION, 2015–2022 (USD MILLION)
Table 54 NORTH AMERICA: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR DOWNSTREAM PROCESSING EQUIPMENT, BY COUNTRY, 2015–2022 (USD MILLION)
Table 55 EUROPE: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, FOR DOWNSTREAM PROCESSING EQUIPMENT, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
Table 56 ASIA-PACIFIC: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, FOR DOWNSTREAM PROCESSING EQUIPMENT, BY COUNTRY, 2015–2022 (USD MILLION)
Table 57 NORTH AMERICA: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, FOR CHROMATOGRAPHY SYSTEMS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 58 EUROPE: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, FOR CHROMATOGRAPHY SYSTEMS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 59 ASIA-PACIFIC: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, FOR CHROMATOGRAPHY SYSTEMS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 60 NORTH AMERICA: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, FOR FLITRATION SYSTEMS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 61 EUROPE: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, FOR FLITRATION SYSTEMS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 62 ASIA-PACIFIC: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, FOR FILTRATION SYSTEMS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 63 PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 64 PHARMACEUTICAL CONTINUOUS END PRODUCT MANUFACTURING MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
Table 65 NORTH AMERICA: PHARMACEUTICAL CONTINUOUS END PRODUCT MANUFACTURING MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 66 EUROPE: PHARMACEUTICAL CONTINUOUS END PRODUCT MANUFACTURING MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 67 ASIA-PACIFIC: PHARMACEUTICAL CONTINUOUS END PRODUCT MANUFACTURING MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 68 PHARMACEUTICAL CONTINUOUS END PRODUCT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2015–2022 (USD MILLION)
Table 69 PHARMACEUTICAL CONTINUOUS SOLID DOSE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
Table 70 NORTH AMERICA: PHARMACEUTICAL CONTINUOUS SOLID DOSE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 71 EUROPE: PHARMACEUTICAL CONTINUOUS SOLID DOSE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 72 ASIA-PACIFIC: PHARMACEUTICAL CONTINUOUS SOLID DOSE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 73 PHARMACEUTICAL CONTINUOUS LIQUID DOSE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
Table 74 NORTH AMERICA: PHARMACEUTICAL CONTINUOUS LIQUID DOSE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 75 EUROPE: CONTINUOUS LIQUID DOSE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 76 ASIA-PACIFIC: PHARMACEUTICAL CONTINUOUS LIQUID DOSE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 77 PHARMACEUTICAL CONTINUOUS API MANUFACTURING MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
Table 78 NORTH AMERICA: PHARMACEUTICAL CONTINUOUS API MANUFACTURING MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 79 EUROPE: PHARMACEUTICAL CONTINUOUS API MANUFACTURING MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 80 ASIA-PACIFIC: PHARMACEUTICAL CONTINUOUS API MANUFACTURING MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 81 PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2015–2022 (USD MILLION)
Table 82 PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR FULL-SCALE MANUFACTURING COMPANIES, BY TYPE, 2015–2022 (USD MILLION)
Table 83 PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR FULL-SCALE MANUFACTURING COMPANIES, BY REGION, 2015–2022 (USD MILLION)
Table 84 NORTH AMERICA: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR FULL-SCALE MANUFACTURING COMPANIES, BY COUNTRY, 2015–2022 (USD MILLION)
Table 85 EUROPE: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR FULL-SCALE MANUFACTURING COMPANIES, BY COUNTRY, 2015–2022 (USD MILLION)
Table 86 ASIA-PACIFIC: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR FULL-SCALE MANUFACTURING COMPANIES, BY COUNTRY, 2015–2022 (USD MILLION)
Table 87 PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR PHARMACEUTICAL COMPANIES, BY REGION, 2015–2022 (USD MILLION)
Table 88 NORTH AMERICA: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2015–2022 (USD MILLION)
Table 89 EUROPE: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2015–2022 (USD MILLION)
Table 90 ASIA-PACIFIC: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2015–2022 (USD MILLION)
Table 91 PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2015–2022 (USD MILLION)
Table 92 ASIA-PACIFIC: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR CONTRACT MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 93 NORTH AMERICA: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR CONTRACT MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 94 EUROPE: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR CONTRACT MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 95 PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR R&D DEPARTMENTS, BY TYPE, 2015–2022 (USD MILLION)
Table 96 PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR R&D DEPARTMENTS, BY REGION, 2015–2022 (USD MILLION)
Table 97 NORTH AMERICA: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR R&D DEPARTMENTS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 98 EUROPE: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR R&D DEPARTMENTS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 99 APAC: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR R&D DEPARTMENTS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 100 PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2015–2022 (USD MILLION)
Table 101 NORTH AMERICA: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 102 EUROPE: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 103 ASIA-PACIFIC: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 104 PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR RESEARCH INSTITUTES, BY REGION, 2015–2022 (USD MILLION)
Table 105 NORTH AMERICA: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR RESEARCH INSTITUTES, BY COUNTRY, 2015–2022 (USD MILLION)
Table 106 EUROPE: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR RESEARCH INSTITUTES, BY COUNTRY, 2015–2022 (USD MILLION)
Table 107 ASIA-PACIFIC: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR RESEARCH INSTITUTES, BY COUNTRY, 2015–2022 (USD MILLION)
Table 108 BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2015–2022 (USD MILLION)
Table 109 BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR MANUFACTURING COMPANIES, BY REGION, 2015–2022 (USD MILLION)
Table 110 NORTH AMERICA: CONTINUOUS MANUFACTURING MARKET SIZE FOR FULL-SCALE MANUFACTURING COMPANIES, BY COUNTRY, 2015–2022 (USD MILLION)
Table 111 ASIA-PACIFIC: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR FULL-SCALE MANUFACTURING COMPANIES, BY COUNTRY, 2015–2022 (USD MILLION)
Table 112 EUROPE: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR FULL-SCALE MANUFACTURING COMPANIES, BY COUNTRY, 2015–2022 (USD MILLION)
Table 113 BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR R&D DEPARTMENTS, BY REGION, 2015–2022 (USD MILLION)
Table 114 NORTH AMERICA: CONTINUOUS MANUFACTURING MARKET SIZE FOR R&D DEPARTMENTS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 115 EUROPE: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR R&D DEPARTMENTS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 116 APAC: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR R&D DEPARTMENTS, BY COUNTRY, 2015–2022 (USD MILLION)
Table 117 GLOBAL CONTINUOUS MANUFACTURING MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
Table 118 GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
Table 119 GLOBAL BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY REGION, 2015–2022 (USD MILLION)
Table 120 NORTH AMERICA: CONTINUOUS MANUFACTURING MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 121 NORTH AMERICA: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 122 NORTH AMERICA: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2015–2022 (USD MILLION)
Table 123 NORTH AMERICA: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 124 NORTH AMERICA: PHARMACEUTICAL END PRODUCT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2015–2022 (USD MILLION)
Table 125 NORTH AMERICA: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2015–2022 (USD MILLION)
Table 126 NORTH AMERICA: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR FULL-SCALE MANUFACTURING COMPANIES, BY TYPE, 2015–2022 (USD MILLION)
Table 127 NORTH AMERICA: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR R&D DEPARTMENTS, BY TYPE, 2015–2022 (USD MILLION)
Table 128 NORTH AMERICA: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 129 NORTH AMERICA: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY EQUIPMENT, 2015–2022 (USD MILLION)
Table 130 NORTH AMERICA: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY UPSTREAM EQUIPMENT, 2015–2022 (USD MILLION)
Table 131 NORTH AMERICA: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DOWNSTREAM EQUIPMENT, 2015–2022 (USD MILLION)
Table 132 NORTH AMERICA: CONTINUOUS MANUFACTURING MARKET SIZE, BY END-USER, 2015–2022 (USD MILLION)
Table 133 U.S.: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2015–2022 (USD MILLION)
Table 134 U.S.: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 135 U.S.: PHARMACEUTICAL END PRODUCT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2015–2022 (USD MILLION)
Table 136 U.S.: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2015–2022 (USD MILLION)
Table 137 U.S.: CONTINUOUS MANUFACTURING MARKET SIZE FOR FULL-SCALE MANUFACTURING COMPANIES, BY TYPE, 2015–2022 (USD MILLION)
Table 138 U.S.: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR R&D DEPARTMENTS, BY TYPE, 2015–2022 (USD MILLION)
Table 139 U.S.: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY EQUIPMENT, 2015–2022 (USD MILLION)
Table 140 U.S.: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY UPSTREAM EQUIPMENT, 2015–2022 (USD MILLION)
Table 141 U.S.: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DOWNSTREAM EQUIPMENT, 2015–2022 (USD MILLION)
Table 142 U.S.: CONTINUOUS MANUFACTURING MARKET SIZE, BY END-USER, 2015–2022 (USD MILLION)
Table 143 CANADA: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2015–2022 (USD MILLION)
Table 144 CANADA: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 145 CANADA: PHARMACEUTICAL END PRODUCT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2015–2022 (USD MILLION)
Table 146 CANADA: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2015–2022 (USD MILLION)
Table 147 CANADA: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR FULL-SCALE MANUFACTURING COMPANIES, BY TYPE, 2015–2022 (USD MILLION)
Table 148 CANADA: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR R&D DEPARTMENTS, BY TYPE, 2015–2022 (USD MILLION)
Table 149 CANADA: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY EQUIPMENT, 2015–2022 (USD MILLION)
Table 150 CANADA: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY UPSTREAM EQUIPMENT, 2015–2022 (USD MILLION)
Table 151 CANADA: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DOWNSTREAM EQUIPMENT, 2015–2022 (USD MILLION)
Table 152 CANADA: CONTINUOUS MANUFACTURING MARKET SIZE, BY END-USER, 2015–2022 (USD MILLION)
Table 153 EUROPE: CONTINUOUS MANUFACTURING MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 154 EUROPE: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2015–2022 (USD MILLION)
Table 155 EUROPE: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 156 EUROPE: PHARMACEUTICAL END PRODUCT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2015–2022 (USD MILLION)
Table 157 EUROPE: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2015–2022 (USD MILLION)
Table 158 EUROPE: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR FULL-SCALE MANUFACTURING COMPANIES, BY TYPE, 2015–2022 (USD MILLION)
Table 159 EUROPE: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR R&D DEPARTMENTS, BY TYPE, 2015–2022 (USD MILLION)
Table 160 EUROPE: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 161 EUROPE: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY EQUIPMENT, 2015–2022 (USD MILLION)
Table 162 EUROPE: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY UPSTREAM EQUIPMENT, 2015–2022 (USD MILLION)
Table 163 EUROPE: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DOWNSTREAM EQUIPMENT, 2015–2022 (USD MILLION)
Table 164 EUROPE: CONTINUOUS MANUFACTURING MARKET SIZE, BY END-USER, 2015–2022 (USD MILLION)
Table 165 GERMANY: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2015–2022 (USD MILLION)
Table 166 GERMANY: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 167 GERMANY: END PRODUCT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2015–2022 (USD MILLION)
Table 168 GERMANY: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2015–2022 (USD MILLION)
Table 169 GERMANY: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR FULL-SCALE MANUFACTURING COMPANIES, BY TYPE, 2015–2022 (USD MILLION)
Table 170 GERMANY: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR R&D DEPARTMENTS, BY TYPE, 2015–2022 (USD MILLION)
Table 171 GERMANY: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY EQUIPMENT, 2015–2022 (USD MILLION)
Table 172 GERMANY: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY UPSTREAM EQUIPMENT, 2015–2022 (USD MILLION)
Table 173 GERMANY: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DOWNSTREAM EQUIPMENT, 2015–2022 (USD MILLION)
Table 174 GERMANY: CONTINUOUS MANUFACTURING MARKET SIZE, BY END-USER, 2015–2022 (USD MILLION)
Table 175 U.K.: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2015–2022 (USD MILLION)
Table 176 U.K.: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 177 U.K.: PHARMACEUTICAL END PRODUCT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2015–2022 (USD MILLION)
Table 178 U.K.: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2015–2022 (USD MILLION)
Table 179 U.K.: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR FULL-SCALE MANUFACTURING COMPANIES, BY TYPE, 2015–2022 (USD MILLION)
Table 180 U.K.: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR R&D DEPARTMENTS, BY TYPE, 2015–2022 (USD MILLION)
Table 181 U.K.: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY EQUIPMENT, 2015–2022 (USD MILLION)
Table 182 U.K.: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY UPSTREAM EQUIPMENT, 2015–2022 (USD MILLION)
Table 183 U.K.: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DOWNSTREAM EQUIPMENT, 2015–2022 (USD MILLION)
Table 184 U.K.: CONTINUOUS MANUFACTURING MARKET SIZE, BY END-USER, 2015–2022 (USD MILLION)
Table 185 REST OF EUROPE: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2015–2022 (USD MILLION)
Table 186 REST OF EUROPE: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 187 REST OF EUROPE: PHARMACEUTICAL END PRODUCT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2015–2022 (USD MILLION)
Table 188 REST OF EUROPE: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2015–2022 (USD MILLION)
Table 189 REST OF EUROPE: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR FULL-SCALE MANUFACTURING COMPANIES, BY TYPE, 2015–2022 (USD MILLION)
Table 190 REST OF EUROPE: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR R&D DEPARTMENTS, BY TYPE, 2015–2022 (USD MILLION)
Table 191 ROE: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY EQUIPMENT, 2015–2022 (USD MILLION)
Table 192 ROE: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY UPSTREAM EQUIPMENT, 2015–2022 (USD MILLION)
Table 193 ROE: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DOWNSTREAM EQUIPMENT, 2015–2022 (USD MILLION)
Table 194 ROE: CONTINUOUS MANUFACTURING MARKET SIZE, BY END-USER, 2015–2022 (USD MILLION)
Table 195 APAC: CONTINUOUS MANUFACTURING MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 196 APAC: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 197 APAC: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2015–2022 (USD MILLION)
Table 198 APAC: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 199 APAC: PHARMACEUTICAL END PRODUCT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2015–2022 (USD MILLION)
Table 200 APAC: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2015–2022 (USD MILLION)
Table 201 APAC: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR FULL-SCALE MANUFACTURING COMPANIES, BY TYPE, 2015–2022 (USD MILLION)
Table 202 APAC: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR R&D DEPARTMENTS, BY TYPE, 2015–2022 (USD MILLION)
Table 203 APAC: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION)
Table 204 APAC: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY EQUIPMENT, 2015–2022 (USD MILLION)
Table 205 APAC: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY UPSTREAM EQUIPMENT, 2015–2022 (USD MILLION)
Table 206 APAC: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DOWNSTREAM EQUIPMENT, 2015–2022 (USD MILLION)
Table 207 APAC: CONTINUOUS MANUFACTURING MARKET SIZE, BY END-USER, 2015–2022 (USD MILLION)
Table 208 SINGAPORE: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2015–2022 (USD MILLION)
Table 209 SINGAPORE: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 210 SINGAPORE: PHARMACEUTICAL END PRODUCT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2015–2022 (USD MILLION)
Table 211 SINGAPORE: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2015–2022 (USD MILLION)
Table 212 SINGAPORE: CONTINUOUS MANUFACTURING MARKET SIZE FOR FULL-SCALE MANUFACTURING COMPANIES, BY TYPE, 2015–2022 (USD MILLION)
Table 213 SINGAPORE: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR R&D DEPARTMENTS, BY TYPE, 2015–2022 (USD MILLION)
Table 214 SINGAPORE: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY EQUIPMENT, 2015–2022 (USD MILLION)
Table 215 SINGAPORE: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY UPSTREAM EQUIPMENT, 2015–2022 (USD MILLION)
Table 216 SINGAPORE: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DOWNSTREAM EQUIPMENT, 2015–2022 (USD MILLION)
Table 217 SINGAPORE: CONTINUOUS MANUFACTURING MARKET SIZE, BY END-USER, 2015–2022 (USD MILLION)
Table 218 CHINA: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2015–2022 (USD MILLION)
Table 219 CHINA: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 220 CHINA: PHARMACEUTICAL END PRODUCT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2015–2022 (USD MILLION)
Table 221 CHINA: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2015–2022 (USD MILLION)
Table 222 CHINA: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR FULL-SCALE MANUFACTURING COMPANIES, BY TYPE, 2015–2022 (USD MILLION)
Table 223 CHINA: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR R&D DEPARTMENTS, BY TYPE, 2015–2022 (USD MILLION)
Table 224 CHINA: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY EQUIPMENT, 2015–2022 (USD MILLION)
Table 225 CHINA: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY UPSTREAM EQUIPMENT, 2015–2022 (USD MILLION)
Table 226 CHINA: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DOWNSTREAM EQUIPMENT, 2015–2022 (USD MILLION)
Table 227 CHINA: CONTINUOUS MANUFACTURING MARKET SIZE, BY END-USER, 2015–2022 (USD MILLION)
Table 228 JAPAN: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2015–2022 (USD MILLION)
Table 229 JAPAN: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 230 JAPAN: PHARMACEUTICAL END PRODUCT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2015–2022 (USD MILLION)
Table 231 JAPAN: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2015–2022 (USD MILLION)
Table 232 JAPAN: CONTINUOUS MANUFACTURING MARKET SIZE FOR FULL-SCALE MANUFACTURING COMPANIES, BY TYPE, 2015–2022 (USD MILLION)
Table 233 JAPAN: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR R&D DEPARTMENTS, BY TYPE, 2015–2022 (USD MILLION)
Table 234 JAPAN: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY EQUIPMENT, 2015–2022 (USD MILLION)
Table 235 JAPAN: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY UPSTREAM EQUIPMENT, 2015–2022 (USD MILLION)
Table 236 JAPAN: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DOWNSTREAM EQUIPMENT, 2015–2022 (USD MILLION)
Table 237 JAPAN: CONTINUOUS MANUFACTURING MARKET SIZE, BY END-USER, 2015–2022 (USD MILLION)
Table 238 ROAPAC: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2015–2022 (USD MILLION)
Table 239 ROAPAC: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 240 ROAPAC: PHARMACEUTICAL END PRODUCT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2015–2022 (USD MILLION)
Table 241 ROAPAC: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2015–2022 (USD MILLION)
Table 242 ROAPAC: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR FULL-SCALE MANUFACTURING COMPANIES, BY TYPE, 2015–2022 (USD MILLION)
Table 243 ROAPAC: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR R&D DEPARTMENTS, BY TYPE, 2015–2022 (USD MILLION)
Table 244 ROAPAC: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY EQUIPMENT, 2015–2022 (USD MILLION)
Table 245 ROAPAC: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY UPSTREAM EQUIPMENT, 2015–2022 (USD MILLION)
Table 246 ROAPAC: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DOWNSTREAM EQUIPMENT, 2015–2022 (USD MILLION)
Table 247 ROAPAC: CONTINUOUS MANUFACTURING MARKET SIZE, BY END-USER, 2015–2022 (USD MILLION)
Table 248 ROW: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2015–2022 (USD THOUSAND)
Table 249 ROW: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 250 ROW: PHARMACEUTICAL END PRODUCT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2015–2022 (USD MILLION)
Table 251 ROW: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2015–2022 (USD MILLION)
Table 252 ROW: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR FULL-SCALE MANUFACTURING COMPANIES, BY TYPE, 2015–2022 (USD MILLION)
Table 253 ROW: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE FOR R&D DEPARTMENTS, BY TYPE, 2015–2022 (USD MILLION)
Table 254 ROW: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY EQUIPMENT, 2015–2022 (USD MILLION)
Table 255 ROW: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY UPSTREAM EQUIPMENT, 2015–2022 (USD MILLION)
Table 256 ROW: BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DOWNSTREAM EQUIPMENT, 2015–2022 (USD MILLION)
Table 257 ROW: CONTINUOUS MANUFACTURING MARKET SIZE, BY END-USER, 2015–2022 (USD MILLION)
LIST OF FIGURES
Figure 1 RESEARCH DESIGN
Figure 2 MARKET SIZE ESTIMATION METHODOLOGY (PHARMACEUTICAL): BOTTOM-UP APPROACH
Figure 3 MARKET SIZE ESTIMATION METHODOLOGY (BIOPHARMACEUTICAL): BOTTOM-UP APPROACH
Figure 4 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
Figure 5 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
Figure 6 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
Figure 7 DATA TRIANGULATION METHODOLOGY
Figure 8 PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2017 VS. 2022 (USD MILLION)
Figure 9 PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2017 VS. 2022 (USD MILLION)
Figure 10 GEOGRAPHICAL SNAPSHOT OF THE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET
Figure 1 BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2017 VS. 2022 (USD MILLION)
Figure 2 BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2017 VS. 2022 (USD MILLION)
Figure 1 GEOGRAPHICAL SNAPSHOT OF THE BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET
Figure 2 EFFICIENCY IN PHARMACEUTICAL MANUFACTURING, AN IMPORTANT GROWTH DRIVER
Figure 3 INTEGRATED SYSTEMS SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET IN 2016
Figure 4 END PRODUCT MANUFACTURING SEGMENT WILL CONTINUE TO DOMINATE THE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET IN 2017 AND 2022
Figure 5 FULL SCALE PHARMACEUTICAL MANUFACTURING TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
Figure 6 NORTH AMERICA TO REGISTER THE HIGHEST CAGR IN THE FORECAST PERIOD (2017–2022)
Figure 7 UPSTREAM EQUIPMENT SEGMENT WILL CONTINUE TO DOMINATE THE CONTINUOUS MANUFACTURING MARKET IN 2017 AND 2022
Figure 8 MANUFACTURING COMPANIES TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
Figure 9 ASIA-PACIFIC TO REGISTER THE HIGHEST CAGR IN THE FORECAST PERIOD (2017–2022)
Figure 10 CONTINUOUS MANUFACTURING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES
Figure 11 PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2017 VS. 2022 (USD MILLION)
Figure 12 BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2017 VS. 2022 (USD MILLION)
Figure 13 PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2017 VS. 2022 (USD MILLION)
Figure 14 FULL-SCALE PHARMACEUTICAL MANUFACTURING COMPANIES SEGMENT TO DOMINATE THE END-USER MARKET IN 2017
Figure 15 MANUFACTURING COMPANIES SEGMENT TO DOMINATE THE END-USER MARKET IN 2017 (BIOPHARMACEUTICAL)
Figure 16 NORTH AMERICA TO DOMINATE THE GLOBAL CONTINUOUS MANUFACTURING MARKET IN 2017
Figure 17 NORTH AMERICA TO DOMINATE THE GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET IN 2017
Figure 1 NORTH AMERICA TO DOMINATE THE GLOBAL BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET IN 2017
Figure 2 NORTH AMERICA: CONTINUOUS MANUFACTURING MARKET SNAPSHOT
Figure 3 EUROPE: CONTINUOUS MANUFACTURING MARKET SNAPSHOT
Figure 4 APAC: CONTINUOUS MANUFACTURING MARKET SNAPSHOT
Figure 5 VENDOR DIVE CHART: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET
Figure 6 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2016)
Figure 7 THERMO FISHER SCIENTIFIC INC.: PRODUCT OFFERING SCORECARD
Figure 8 THERMO FISHER SCIENTIFIC INC.: BUSINESS STRATEGY SCORECARD
Figure 9 GEA GROUP AG: COMPANY SNAPSHOT (2016)
Figure 10 GEA GROUP AG: PRODUCT OFFERING SCORECARD
Figure 11 GEA GROUP AG: BUSINESS STRATEGY SCORECARD
Figure 12 HOSOKAWA MICRON CORPORATION: COMPANY SNAPSHOT (2016)
Figure 13 HOSOKAWA MICRON CORPORATION: PRODUCT OFFERING SCORECARD
Figure 14 HOSOKAWA MICRON CORPORATION: BUSINESS STRATEGY SCORECARD
Figure 15 COPERION GMBH: PRODUCT OFFERING SCORECARD
Figure 16 COPERION GMBH: BUSINESS STRATEGY SCORECARD
Figure 17 GLATT GMBH: PRODUCT OFFERING SCORECARD
Figure 18 GLATT GMBH: BUSINESS STRATEGY SCORECARD
Figure 19 KORSCH AG: PRODUCT OFFERING SCORECARD
Figure 20 KORSCH AG: BUSINESS STRATEGY SCORECARD
Figure 21 MUNSON MACHINERY COMPANY, INC.: PRODUCT OFFERING SCORECARD
Figure 22 MUNSON MACHINERY COMPANY, INC.: BUSINESS STRATEGY SCORECARD
Figure 23 L.B. BOHLE MASCHINEN + VERFAHREN GMBH: PRODUCT OFFERING SCORECARD
Figure 24 L.B. BOHLE MASCHINEN + VERFAHREN GMBH: BUSINESS STRATEGY SCORECARD
Figure 25 BOSCH PACKAGING TECHNOLOGY: PRODUCT OFFERING SCORECARD
Figure 26 BOSCH PACKAGING TECHNOLOGY: BUSINESS STRATEGY SCORECARD
Figure 27 GEBRÜDER LÖDIGE MASCHINENBAU GMBH: PRODUCT OFFERING SCORECARD
Figure 28 GEBRÜDER LÖDIGE MASCHINENBAU GMBH: BUSINESS STRATEGY SCORECARD
Figure 29 BAKER PERKINS LTD.: PRODUCT OFFERING SCORECARD
Figure 30 BAKER PERKINS LTD.: BUSINESS STRATEGY SCORECARD
Figure 31 SCOTT EQUIPMENT COMPANY: PRODUCT OFFERING SCORECARD
Figure 32 SCOTT EQUIPMENT COMPANY: BUSINESS STRATEGY SCORECARD
Figure 33 STURTEVANT, INC.: PRODUCT OFFERING SCORECARD
Figure 34 STURTEVANT, INC.: BUSINESS STRATEGY SCORECARD
Figure 35 SARTORIUS STEDIM BIOTECH: COMPANY SNAPSHOT (2016)
Figure 36 GE HEALTHCARE: COMPANY SNAPSHOT
Figure 37 MERCK KGAA: COMPANY SNAPSHOT
Figure 38 REPLIGEN: COMPANY SNAPSHOT
Figure 39 DANAHER CORPORATION: COMPANY SNAPSHOT
Figure 1 RESEARCH DESIGN
Figure 2 MARKET SIZE ESTIMATION METHODOLOGY (PHARMACEUTICAL): BOTTOM-UP APPROACH
Figure 3 MARKET SIZE ESTIMATION METHODOLOGY (BIOPHARMACEUTICAL): BOTTOM-UP APPROACH
Figure 4 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
Figure 5 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
Figure 6 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
Figure 7 DATA TRIANGULATION METHODOLOGY
Figure 8 PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2017 VS. 2022 (USD MILLION)
Figure 9 PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2017 VS. 2022 (USD MILLION)
Figure 10 GEOGRAPHICAL SNAPSHOT OF THE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET
Figure 1 BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2017 VS. 2022 (USD MILLION)
Figure 2 BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2017 VS. 2022 (USD MILLION)
Figure 1 GEOGRAPHICAL SNAPSHOT OF THE BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET
Figure 2 EFFICIENCY IN PHARMACEUTICAL MANUFACTURING, AN IMPORTANT GROWTH DRIVER
Figure 3 INTEGRATED SYSTEMS SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET IN 2016
Figure 4 END PRODUCT MANUFACTURING SEGMENT WILL CONTINUE TO DOMINATE THE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET IN 2017 AND 2022
Figure 5 FULL SCALE PHARMACEUTICAL MANUFACTURING TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
Figure 6 NORTH AMERICA TO REGISTER THE HIGHEST CAGR IN THE FORECAST PERIOD (2017–2022)
Figure 7 UPSTREAM EQUIPMENT SEGMENT WILL CONTINUE TO DOMINATE THE CONTINUOUS MANUFACTURING MARKET IN 2017 AND 2022
Figure 8 MANUFACTURING COMPANIES TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
Figure 9 ASIA-PACIFIC TO REGISTER THE HIGHEST CAGR IN THE FORECAST PERIOD (2017–2022)
Figure 10 CONTINUOUS MANUFACTURING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES
Figure 11 PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2017 VS. 2022 (USD MILLION)
Figure 12 BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PRODUCT, 2017 VS. 2022 (USD MILLION)
Figure 13 PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2017 VS. 2022 (USD MILLION)
Figure 14 FULL-SCALE PHARMACEUTICAL MANUFACTURING COMPANIES SEGMENT TO DOMINATE THE END-USER MARKET IN 2017
Figure 15 MANUFACTURING COMPANIES SEGMENT TO DOMINATE THE END-USER MARKET IN 2017 (BIOPHARMACEUTICAL)
Figure 16 NORTH AMERICA TO DOMINATE THE GLOBAL CONTINUOUS MANUFACTURING MARKET IN 2017
Figure 17 NORTH AMERICA TO DOMINATE THE GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET IN 2017
Figure 1 NORTH AMERICA TO DOMINATE THE GLOBAL BIOPHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET IN 2017
Figure 2 NORTH AMERICA: CONTINUOUS MANUFACTURING MARKET SNAPSHOT
Figure 3 EUROPE: CONTINUOUS MANUFACTURING MARKET SNAPSHOT
Figure 4 APAC: CONTINUOUS MANUFACTURING MARKET SNAPSHOT
Figure 5 VENDOR DIVE CHART: PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET
Figure 6 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2016)
Figure 7 THERMO FISHER SCIENTIFIC INC.: PRODUCT OFFERING SCORECARD
Figure 8 THERMO FISHER SCIENTIFIC INC.: BUSINESS STRATEGY SCORECARD
Figure 9 GEA GROUP AG: COMPANY SNAPSHOT (2016)
Figure 10 GEA GROUP AG: PRODUCT OFFERING SCORECARD
Figure 11 GEA GROUP AG: BUSINESS STRATEGY SCORECARD
Figure 12 HOSOKAWA MICRON CORPORATION: COMPANY SNAPSHOT (2016)
Figure 13 HOSOKAWA MICRON CORPORATION: PRODUCT OFFERING SCORECARD
Figure 14 HOSOKAWA MICRON CORPORATION: BUSINESS STRATEGY SCORECARD
Figure 15 COPERION GMBH: PRODUCT OFFERING SCORECARD
Figure 16 COPERION GMBH: BUSINESS STRATEGY SCORECARD
Figure 17 GLATT GMBH: PRODUCT OFFERING SCORECARD
Figure 18 GLATT GMBH: BUSINESS STRATEGY SCORECARD
Figure 19 KORSCH AG: PRODUCT OFFERING SCORECARD
Figure 20 KORSCH AG: BUSINESS STRATEGY SCORECARD
Figure 21 MUNSON MACHINERY COMPANY, INC.: PRODUCT OFFERING SCORECARD
Figure 22 MUNSON MACHINERY COMPANY, INC.: BUSINESS STRATEGY SCORECARD
Figure 23 L.B. BOHLE MASCHINEN + VERFAHREN GMBH: PRODUCT OFFERING SCORECARD
Figure 24 L.B. BOHLE MASCHINEN + VERFAHREN GMBH: BUSINESS STRATEGY SCORECARD
Figure 25 BOSCH PACKAGING TECHNOLOGY: PRODUCT OFFERING SCORECARD
Figure 26 BOSCH PACKAGING TECHNOLOGY: BUSINESS STRATEGY SCORECARD
Figure 27 GEBRÜDER LÖDIGE MASCHINENBAU GMBH: PRODUCT OFFERING SCORECARD
Figure 28 GEBRÜDER LÖDIGE MASCHINENBAU GMBH: BUSINESS STRATEGY SCORECARD
Figure 29 BAKER PERKINS LTD.: PRODUCT OFFERING SCORECARD
Figure 30 BAKER PERKINS LTD.: BUSINESS STRATEGY SCORECARD
Figure 31 SCOTT EQUIPMENT COMPANY: PRODUCT OFFERING SCORECARD
Figure 32 SCOTT EQUIPMENT COMPANY: BUSINESS STRATEGY SCORECARD
Figure 33 STURTEVANT, INC.: PRODUCT OFFERING SCORECARD
Figure 34 STURTEVANT, INC.: BUSINESS STRATEGY SCORECARD
Figure 35 SARTORIUS STEDIM BIOTECH: COMPANY SNAPSHOT (2016)
Figure 36 GE HEALTHCARE: COMPANY SNAPSHOT
Figure 37 MERCK KGAA: COMPANY SNAPSHOT
Figure 38 REPLIGEN: COMPANY SNAPSHOT
Figure 39 DANAHER CORPORATION: COMPANY SNAPSHOT
